Skip to Main Content

Paper Details

The kinase polypharmacology landscape of clinical PARP inhibitors.
Sci Rep
58
2020
Author NameAffiliation
Malaka AmeratungaThe Institute of Cancer Research
Paul WorkmanThe Institute of Cancer Research
Bissan Al-LazikaniThe Institute of Cancer Research
Bissan Al-LazikaniThe Institute of Cancer Research
  • 1 - 4

Datasets

Release 1.2